220 related articles for article (PubMed ID: 25936516)
21. Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases.
Chojnacki K; Wińska P; Wielechowska M; Łukowska-Chojnacka E; Tölzer C; Niefind K; Bretner M
Bioorg Chem; 2018 Oct; 80():266-275. PubMed ID: 29966873
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.
Franck N; Le Seyec J; Guguen-Guillouzo C; Erdtmann L
J Virol; 2005 Mar; 79(5):2700-8. PubMed ID: 15708989
[TBL] [Abstract][Full Text] [Related]
23. Functional proteomics strategy for validation of protein kinase inhibitors reveals new targets for a TBB-derived inhibitor of protein kinase CK2.
Gyenis L; Kuś A; Bretner M; Litchfield DW
J Proteomics; 2013 Apr; 81():70-9. PubMed ID: 23017496
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase CK2 phosphorylates and upregulates Akt/PKB.
Di Maira G; Salvi M; Arrigoni G; Marin O; Sarno S; Brustolon F; Pinna LA; Ruzzene M
Cell Death Differ; 2005 Jun; 12(6):668-77. PubMed ID: 15818404
[TBL] [Abstract][Full Text] [Related]
25. Mutation of recombinant catalytic subunit alpha of the protein kinase CK2 that affects catalytic efficiency and specificity.
Chaillot D; Declerck N; Niefind K; Schomburg D; Chardot T; Meunier JC
Protein Eng; 2000 Apr; 13(4):291-8. PubMed ID: 10810161
[TBL] [Abstract][Full Text] [Related]
26. Purification and characterization of maize seedling casein kinase IIB, a monomeric enzyme immunologically related to the alpha subunit of animal casein kinase-2.
Dobrowolska G; Meggio F; Szczegielniak J; Muszynska G; Pinna LA
Eur J Biochem; 1992 Feb; 204(1):299-303. PubMed ID: 1740141
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory influence of natural flavonoids on human protein kinase CK2 isoforms: effect of the regulatory subunit.
Baier A; Nazaruk J; Galicka A; Szyszka R
Mol Cell Biochem; 2018 Jul; 444(1-2):35-42. PubMed ID: 29188536
[TBL] [Abstract][Full Text] [Related]
28. Regulation of caspase pathways by protein kinase CK2: identification of proteins with overlapping CK2 and caspase consensus motifs.
Turowec JP; Duncan JS; Gloor GB; Litchfield DW
Mol Cell Biochem; 2011 Oct; 356(1-2):159-67. PubMed ID: 21750976
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel CK2 inhibitors with a benzofuran scaffold by novel non-radiometric in vitro assays.
Gratz A; Kuckländer U; Bollig R; Götz C; Jose J
Mol Cell Biochem; 2011 Oct; 356(1-2):83-90. PubMed ID: 21750981
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase CK2 interacts with the splicing factor hPrp3p.
Lehnert S; Götz C; Kartarius S; Schäfer B; Montenarh M
Oncogene; 2008 Apr; 27(17):2390-400. PubMed ID: 18026141
[TBL] [Abstract][Full Text] [Related]
31. CIGB-300 Peptide Targets the CK2 Phospho-Acceptor Domain on Human Papillomavirus E7 and Disrupts the Retinoblastoma (RB) Complex in Cervical Cancer Cells.
Ramón AC; Basukala O; Massimi P; Thomas M; Perera Y; Banks L; Perea SE
Viruses; 2022 Jul; 14(8):. PubMed ID: 36016303
[TBL] [Abstract][Full Text] [Related]
32. The Role of p38 and CK2 Protein Kinases in the Response of RAW 264.7 Macrophages to Lipopolysaccharide.
Glushkova OV; Parfenyuk SB; Novoselova TV; Khrenov MO; Lunin SM; Novoselova EG
Biochemistry (Mosc); 2018 Jun; 83(6):746-754. PubMed ID: 30195331
[TBL] [Abstract][Full Text] [Related]
33. Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunits.
Salvi M; Sarno S; Marin O; Meggio F; Itarte E; Pinna LA
FEBS Lett; 2006 Jul; 580(16):3948-52. PubMed ID: 16806200
[TBL] [Abstract][Full Text] [Related]
34. Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells.
Franchin C; Cesaro L; Salvi M; Millioni R; Iori E; Cifani P; James P; Arrigoni G; Pinna L
Biochim Biophys Acta; 2015 Jun; 1854(6):609-23. PubMed ID: 25278378
[TBL] [Abstract][Full Text] [Related]
35. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
36. Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity.
Perera Y; Farina HG; Gil J; Rodriguez A; Benavent F; Castellanos L; Gómez RE; Acevedo BE; Alonso DF; Perea SE
Mol Cancer Ther; 2009 May; 8(5):1189-96. PubMed ID: 19417160
[TBL] [Abstract][Full Text] [Related]
37. Protein Kinase CK2 Subunits Differentially Perturb the Adhesion and Migration of GN11 Cells: A Model of Immature Migrating Neurons.
Lettieri A; Borgo C; Zanieri L; D'Amore C; Oleari R; Paganoni A; Pinna LA; Cariboni A; Salvi M
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779225
[TBL] [Abstract][Full Text] [Related]
38. Interactions between subunits of protein kinase CK2 and their protein substrates influences its sensitivity to specific inhibitors.
Janeczko M; Masłyk M; Szyszka R; Baier A
Mol Cell Biochem; 2011 Oct; 356(1-2):121-6. PubMed ID: 21755460
[TBL] [Abstract][Full Text] [Related]
39. Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity.
Tang S; Zhang N; Zhou Y; Cortopassi WA; Jacobson MP; Zhao LJ; Zhong RG
Mol Inform; 2019 Mar; 38(3):e1800089. PubMed ID: 30307134
[TBL] [Abstract][Full Text] [Related]
40. CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer models.
Benavent Acero F; Capobianco CS; Garona J; Cirigliano SM; Perera Y; Urtreger AJ; Perea SE; Alonso DF; Farina HG
Lung Cancer; 2017 May; 107():14-21. PubMed ID: 27319334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
